GLP-1 is produced by specialised enteroendocrine cells called L-cells, which are located predominantly in the distal small intestine (ileum) and colon
It helps the body absorb nutrients better
GLP-1 agonists are a group of medications that help to manage blood sugar in people with Type 2 diabetes, some of which can be used to treat obesity even in people who do not have diabetes
Does the product have a country of origin
At steady state, the concentrations of citaloprams metabolites, DCT and DDCT, in plasma are approximately one-half and one-tenth, respectively, that of the parent drug
Major organizations, including the American Diabetes Association (ADA), echoed this position and publicly advised against using non-FDA-approved compounded incretin products